Business Context and Reporting Period
Deutsche Bank Aktiengesellschaft filed this Form 6-K on January 21, 2016, to disclose an ad hoc release issued on January 20, 2016. The filing provides preliminary full-year and fourth-quarter 2015 financial results. The bank operates under CRR/CRD4 regulatory frameworks implementing Basel III.
Key Financial Metrics
Full Year 2015 (Preliminary)
- Revenue: EUR 33.5 billion
- Loss Before Income Taxes: Approximately EUR 6.1 billion
- Net Loss: Approximately EUR 6.7 billion
- Major Charges Included:
- Goodwill and intangibles impairments: EUR 5.8 billion (taken in Q3)
- Full-year litigation provisions: Approximately EUR 5.2 billion
- Restructuring and severance charges: Approximately EUR 1.0 billion
Fourth Quarter 2015 (Preliminary)
- Revenue: EUR 6.6 billion
- Loss Before Income Taxes: Approximately EUR 2.7 billion
- Net Loss: Approximately EUR 2.1 billion
- Q4 Specific Charges:
- Litigation charges: Approximately EUR 1.2 billion (majority not tax-deductible)
- Restructuring and severance: EUR 0.8 billion (largely Private & Business Clients)
- Software impairment (PBC): EUR 0.1 billion
Capital and Liquidity
- CET1 Ratio (Fully-loaded CRR/CRD4): Approximately 11% at end of Q4 2015.
- Capital Impact: A change in regulatory treatment of the Abbey Life business reduced the CET1 ratio by approximately 10 basis points.
- Asset Sale: The pending sale of a 19.99% stake in Hua Xia Bank is expected to close in Q2 2016. Pro-forma, this would have improved the CET1 ratio by 50 to 60 basis points as of December 31, 2015.
Material Changes and Drivers
The fourth quarter results were significantly impacted by challenging market conditions, leading to a year-over-year revenue decline, particularly in the Corporate Banking & Securities (CB&S) segment. The reported losses are primarily driven by substantial litigation provisions and restructuring costs. The full-year loss includes significant impairments recognized in the third quarter.
Outlook, Risks, and Contingencies
- Forward-Looking Statements: The filing contains estimates and projections subject to risks including financial market conditions, borrower defaults, and the reliability of risk management policies.
- Contingencies: Litigation provisions are preliminary and may change prior to the publication of annual financial statements on March 11, 2016.
- Regulatory Capital: The bank notes that fully loaded CRR/CRD4 measures are non-GAAP and may not be comparable to competitors due to varying assumptions on final rule implementation.
- Next Disclosure: Detailed preliminary results will be disclosed on January 28, 2016.
Investor Verification Checklist
- Verify the final litigation provision amounts in the March 11, 2016 annual financial statements, as current figures are preliminary.
- Confirm the closing date and final financial impact of the Hua Xia Bank stake sale in Q2 2016.
- Review the detailed breakdown of the EUR 5.8 billion goodwill and intangibles impairment taken in Q3 2015.
- Assess the tax deductibility of the EUR 1.2 billion Q4 litigation charge, as the majority is currently expected to be non-deductible.
- Monitor the impact of the Abbey Life business regulatory treatment change on future capital ratios.